Previous 10 | Next 10 |
RxSight ( NASDAQ: RXST ) is trading ~5% lower after Wells Fargo downgraded to equal weight from overweight Wells Fargo analyst Larry Biegelsen believes demand for RxSight's light adjustable lens (LAL) will be sensitive to a possible economic downturn. The analyst said LAL...
RxSight, Inc. (RXST) Q3 2022 Results Conference Call November 07, 2022 04:30 PM ET Company Participants Alex Huang - Associate Director of Investor Relations Ron Kurtz - President and Chief Executive Officer Shelley Thunen - Chief Financial Officer Conferen...
The following slide deck was published by RxSight, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: RxSight, Inc. 2022 Q3 - Results - Earnings Call Presentation
RxSight press release ( NASDAQ: RXST ): Q3 GAAP EPS of -$0.61 beats by $0.10 . Revenue of $12.6M (+118.0% Y/Y) beats by $1.62M . full-year 2022 revenue guidance to a range of $47.0 million to $48.0 million vs $45.26M Consensus For further details see: ...
ALISO VIEJO, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three and nine months ended September 30, 2022. Key Quarterly...
ALISO VIEJO, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the third quarter 2022 after the ...
ALISO VIEJO, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Wells Fargo Healthcare Conference. ...
Image source: The Motley Fool. RxSight, Inc. (NASDAQ: RXST) Q2 2022 Earnings Call Aug 08, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: RxSight, Inc. (RXST) Q2 2022 Earnings Call Transcript
RxSight, Inc. (RXST) Q2 2022 Earnings Conference Call August 08, 2022 04:30 PM ET Company Participants Alex Huang - Investor Relations Ron Kurtz - President and Chief Executive Officer Shelley Thunen - Chief Financial Officer Conference Call Participants ...
RxSight press release ( NASDAQ: RXST ): Q2 Non-GAAP EPS of -$0.50 beats by $0.15 . Revenue of $11.4M (+132.7% Y/Y) beats by $0.85M . For further details see: RxSight Non-GAAP EPS of -$0.50 beats by $0.15, revenue of $11.4M beats by $0.85M
News, Short Squeeze, Breakout and More Instantly...
ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second...
ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference. ...
Shareholders approved all agenda items and proposals of the Board of Directors Robert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of Directors Baruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of th...